日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Cross-Sectional Comparative Analysis of Long Covid Symptoms in a Primary Care Population

初级保健人群中新冠长期症状的横断面比较分析

Duan, Rundan; Ni, Qihong; Li, Yinan; Zhu, Mingli; Li, Wen; Wang, Peng; Yuan, Kai; von Hundelshausen, Philipp; Zhu, Jingpu; Zhang, Lan; Lv, Lei; Lesser, Lenard; Temple, Jennifer

Targeting platelet-derived CXCL12 impedes arterial thrombosis.

靶向血小板衍生的 CXCL12 可抑制动脉血栓形成

Leberzammer Julian, Agten Stijn M, Blanchet Xavier, Duan Rundan, Ippel Hans, Megens Remco T A, Schulz Christian, Aslani Maria, Duchene Johan, Döring Yvonne, Jooss Natalie J, Zhang Pengyu, Brandl Richard, Stark Konstantin, Siess Wolfgang, Jurk Kerstin, Heemskerk Johan W M, Hackeng Tilman M, Mayo Kevin H, Weber Christian, von Hundelshausen Philipp

Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton's Tyrosine Kinase

血液中血小板的自发聚集是由FcγRIIA刺激布鲁顿酪氨酸激酶介导的。

Duan, Rundan; Goldmann, Luise; Li, Ya; Weber, Christian; Siess, Wolfgang; von Hundelshausen, Philipp

Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time

BTK抑制剂Remibrutinib (LOU064)和Rilzabrutinib (PRN1008)对血小板聚集和体外出血时间的影响,以及它们相对于Tec的BTK选择性差异

Duan, Rundan; Goldmann, Luise; Brandl, Richard; Spannagl, Michael; Weber, Christian; Siess, Wolfgang; von Hundelshausen, Philipp

Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

口服布鲁顿酪氨酸激酶抑制剂可阻断血小板Fc受体CD32a(FcγRIIA)的激活:HIT的新选择?

Goldmann, Luise; Duan, Rundan; Kragh, Thorsten; Wittmann, Georg; Weber, Christian; Lorenz, Reinhard; von Hundelshausen, Philipp; Spannagl, Michael; Siess, Wolfgang